ReviewHeliyon2025
An epidemiological model of SIR in a nanotechnological innovation environment.
Review in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Today, when nanotechnological innovation, in particular, faces stringent regulations, the question arises concerning a tool that can quantify individual interventions and thus complement current knowledge in the diffusion theory of innovation. This paper examines the complex nature of innovation diffusion in a rapidly evolving technological environment. The research presents current knowledge in the field linking diffusion of innovation theory and the basic epidemiological model of SIR (Susceptible, Infected, Recovered). Epidemiological models, originally developed to study the spread of infectious diseases, offer intriguing parallels to innovation diffusion due to shared characteristics in propagation dynamics. Integrating the SIR epidemiological model into the current theoretical framework allows the SIR model to be considered as a tool capable of filling current gaps in the literature. Nanotechnological innovations are chosen because of their significant impact on society, which faces unique market entry challenges. Within the framework of high interdisciplinarity, nanotechnologies, like viruses, tend to 'mutate' into different industries where their 'infectivity' varies. The case of nanotechnology serves to illustrate the usefulness of the proposed model and shows how factors that influence the spread of viruses can similarly affect the adoption of technological innovations. Similar characteristics in the propagation framework between innovations and viruses can serve as one of many arguments for the use of the SIR model in this field. Using an integrative review, aspects that have the potential to add to the SIR model in the current literature are identified. By combining epidemiological findings with innovation theory, the paper contributes to a richer and more integrated understanding of the phenomena of diffusion of nanotechnological innovations. The motivation is to open a debate regarding the ability of the epidemiological model of SIR to reveal the impact of interventions affecting the diffusion of innovations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.